Kerri Rivera has been researching methods to recover lives of people with autism and related conditions since 2006.
She completed DAN based training for the biomedical treatment of autism in 2009 (DAN refers to “Defeat Autism Now”).
She has a degree in homeopathy, and has been trained to provide hyperbaric therapy.
She is the developer of the chlorine dioxide protocol, which has been used to recover 557 people from autism and related conditions.
Repatha is a new cholesterol-lowering medication that works differently from statins. It is part of an expensive class of medications that currently costs about $14,000 per year.
When Repatha first came out I predicted that this class of drugs would (similarly to statins) fail and, furthermore, cause too many adverse effects.
When we reviewed the article, we concluded Repatha was not very effective as it failed to help nearly 98% who took it. As we were about to finish our discussion, I said let’s look at the adverse effects from this drug.
Adverse side effects were encountered by 77.4% of those treated with both Repatha and the placebo.
As for serious side effects, 24.8% of the Repatha group and 24.7% of the placebo group suffered a serious adverse effect.
We were both stunned.
How could a therapy have such a high rate of adverse effects, especially serious adverse effects? And, how could a placebo have such a high rate of adverse and serious adverse events?
Canola oil is widely promoted as “one of the best oils for heart health.” However, this information is rather flawed, as canola oil and similar highly processed cooking oils hold untold dangers to your health.
Read on to learn what you should know about canola oil, and what my personal recommendations for the best cooking oil are.
Recently we covered a study published in the journal Clinical Nutrition which compared peanut oil consumption with coconut oil consumption among healthy men in India, where those who consumed coconut oil had better health outcomes in terms of heart disease and diabetes. (See: Coconut oil consumption improves fat-free mass, plasma HDL-cholesterol and insulin sensitivity in healthy men with normal BMI compared to peanut oil.)
A researcher at The University of Edinburgh Medical School wrote a Letter to the Editor of Clinical Nutrition commenting on this study, criticizing current government nutritional guidelines regarding saturated dietary fat restrictions.
"The cross-over study by Korrapati et al. detailed the potential cardioprotective effect of coconut oil, and I would like to thank the authors for their insight. Whilst the sample size was small, it was well-designed to investigate its primary end-points.
This study is particularly topical as, despite removal of the maximum dietary fat intake restriction from guidelines, a major resistance against saturated fats remains."
Setting aside the issue of whether or not saturated fats should be restricted at all, given the abundance of contrary evidence in the medical literature, the Edinburgh Medical School researcher reported that such guidelines do not distinguish between different types of saturated fats. Saturated fats can be found in animal products, such as butter, as well as plant sources, such as coconuts and date palms.
"The rise in high density lipoprotein cholesterol (HDL-c) with coconut oil consumption is certainly a compelling finding. Results from a recent and larger-scale randomised trial by Khaw et al. corroborate this... Evidence suggests that the saturated versus unsaturated distinction of fats is likely an oversimplification.
Korrapati et al. should, therefore, be commended on their focus on the biological properties of coconut oil, particularly the medium chain triglyceride (MCT) dominated fatty acid profile, which may confer atheroprotective effects."
